Figure 2B–2C show that the RSK1 and RSK2 double knockdown reduced the HGF triggered motility of ovarian cancer cells in functional in vitro assays, such as wound closure and directional migration. This evidence concerns the gene RPS6KA1 and ovarian carcinoma.